DESTINY trial | 動物用藥查詢網
由SModi著作·2022·被引用325次—IntheDESTINY-Breast04trial,trastuzumabderuxtecanshowedsuperioractivityoverstandardchemotherapyoptionsinpatientswithHER2-low ...,由SModi著作·2020·被引用1048次—Weperformedaphase2registrationstudyoftrastuzumabderuxtecan(DESTINY-Breast01)inpatientswithHER2-positivemetastaticbreastcancer ...,由JCortés著作·2022·被引用229次—ThesafetyprofileoftrastuzumabderuxtecanwassimilartothatobservedintheDESTINY-Breast01trial.However,theincidenceofinterstitial ...,FindinformationonPh...
HER2-low breast cancer Trastuzumab deruxtecan trastuzumab deruxtecan in previously treated her2-low advanced breast cancer Trastuzumab deruxtecan brain metastases trastuzumab deruxtecan仿單 trastuzumab deruxtecan中文 HER2-low definition Deruxtecan 新功西富力信 150 紅黴素軟膏價格 龍樹菩薩大智度論 中藥降血脂副作用 TISES tylosin雞 百樂鋼筆 癌症安寧療護
Trastuzumab Deruxtecan in Previously Treated HER2 | 動物用藥查詢網
由 S Modi 著作 · 2022 · 被引用 325 次 — In the DESTINY-Breast04 trial, trastuzumab deruxtecan showed superior activity over standard chemotherapy options in patients with HER2-low ... Read More
Trastuzumab Deruxtecan in Previously Treated HER2 | 動物用藥查詢網
由 S Modi 著作 · 2020 · 被引用 1048 次 — We performed a phase 2 registration study of trastuzumab deruxtecan (DESTINY-Breast01) in patients with HER2-positive metastatic breast cancer ... Read More
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for ... | 動物用藥查詢網
由 J Cortés 著作 · 2022 · 被引用 229 次 — The safety profile of trastuzumab deruxtecan was similar to that observed in the DESTINY-Breast01 trial. However, the incidence of interstitial ... Read More
DESTINY Clinical Trials for Metastatic Breast Cancer | 動物用藥查詢網
Find information on Phase 3 fam- trastuzumab deruxtecan (DS-8201) trials; for eligible patients with metastatic breast cancer. Read More
updated results from DESTINY-Breast03 | 動物用藥查詢網
由 SA Hurvitz 著作 · 被引用 16 次 — DESTINY-Breast03 was an open-label, randomised, multicentre, phase 3 trial that evaluated the efficacy and safety of trastuzumab deruxtecan ... Read More
DESTINY | 動物用藥查詢網
2022年6月6日 — DESTINY-Breast04 is the first randomized clinical trial to show that targeting HER2 provides clinically meaningful benefits for patients ... Read More
Trastuzumab Deruxtecan in Previously Treated ... | 動物用藥查詢網
由 S Modi 著作 · 2022 · 被引用 323 次 — In this trial involving patients with HER2-low metastatic breast cancer, trastuzumab deruxtecan ... DESTINY-Breast04 Trial Investigators:. Read More
Trastuzumab Deruxtecan (DS | 動物用藥查詢網
... Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04] ... Meinhardt G, Harbeck N, Cameron DA; DESTINY-Breast04 Trial Investigators. Read More
相關資訊整理
得佳注射液 DERGA INJ
得佳注射液有哪些副作用?由華達化學製藥廠股份有限公司土城工廠製造的得佳注射液是治療什麼的?藥品成分是什麼?以下為大家...
高化維五○○ COFAVIT 500
高化維五○○有哪些副作用?由東盈實業股份有限公司製造的高化維五○○是治療什麼的?藥品成分是什麼?以下為大家提供詳細的「高...